We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Smartphone app Guides Night Blindness Sufferers

By HospiMedica International staff writers
Posted on 15 Aug 2013
Print article
A new app keeps track of location and distance walked from a home or a hotel, warning sufferers of night blindness (nyctalopia), when they are likely to be caught out after dark.

Researchers at the Federal Urdu University of Arts, Science and Technology (Karachi, Pakistan) developed the smartphone app to allow nyctalopia victims to safely leave their home knowing that their phone is keeping track of their whereabouts, calculating both the remaining daylight hours available as well as estimating how long it will take the person to reach their base before nightfall.

The application is geo-aware, knowing the time of sunset around the world, as well as having access to online mapping software, which can offer the potentially vulnerable user with shortcuts back to their base. The app also has an added benefit of being able to locate nearby hotels, should the user need to reach one before darkness falls. The study describing the new app was published in the July 2013 issue of the International Journal Mobile Learning and Organization.

“Night blindness afflicts millions and may be present at birth as a genetic disease, arise in childhood through malnutrition or injury, or be a symptom of numerous eye diseases,” said lead author Kamran Ahsan, PhD. “Sufferers find it difficult or impossible to see in low-light conditions and so can be very much at-risk if darkness falls while they are in a strange city or even in their home town. Of course, many people with nyctalopia never venture from their home environment because of their disability.”

The most common cause of nyctalopia is retinitis pigmentosa, a genetic disorder in which the rod cells in the retina gradually lose their ability to respond to the light. Patients suffering from this condition have progressive nyctalopia, and eventually their daytime vision may also be affected. Other causes include X-linked congenital stationary night blindness, in which the rod cells either do not work at all, or work very little, and night blindness caused by a deficiency of retinol (vitamin A), found in fish oils, liver, and dairy products.

Related Links:
Federal Urdu University of Arts, Science and Technology


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Ureteroscope
URF-P5
New
Opaque X-Ray Mobile Lead Barrier
2594M

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.